HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $570,266 | -4.5% | 6,669 | 0.0% | 0.02% | -11.8% |
Q3 2023 | $597,409 | +132.5% | 6,669 | +72.9% | 0.02% | +112.5% |
Q2 2021 | $257,000 | -34.4% | 3,857 | +9.2% | 0.01% | -46.7% |
Q1 2021 | $392,000 | -16.9% | 3,532 | -11.2% | 0.02% | -31.8% |
Q4 2020 | $472,000 | +42.6% | 3,978 | +4.7% | 0.02% | +15.8% |
Q3 2020 | $331,000 | +26.3% | 3,798 | +29.8% | 0.02% | -55.8% |
Q2 2020 | $262,000 | – | 2,925 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |